Tigecycline sclerotherapy for recurrent pseudotumor in aseptic lymphocyte-dominant vasculitis-associated lesion after metal-on-metal total hip arthroplasty: A case report
I-Hao Lin, Chun-Hao Tsai, Department of Orthopedics, China Medical University Hospital, China Medical University, Taichung 406040, Taiwan
Chun-Hao Tsai, School of Medicine, China Medical University, Taichung 406040, Taiwan
Chun-Hao Tsai, Department of Sports Medicine, China Medical University, Taichung 406040, Taiwan
Author contributions: Tsai CH contributed to the study concept and design; Lin IH and Tsai CH performed data acquisition, Lin IH contributed to manuscript writing; Tsai CH critically revised manuscript, and Lin IH and Tsai CH gave final approval of the manuscript.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Chun-Hao Tsai, MD, PhD, Attending Doctor, Department of Orthopedics, China Medical University Hospital, China Medical University, No. 100 Sec. 1, Jingmao Road, Beitun District, Taichung 406040, Taiwan. firstname.lastname@example.org
Received: June 2, 2021
Peer-review started: June 2, 2021
First decision: June 25, 2021
Revised: July 6, 2021
Accepted: October 20, 2021
Article in press: October 20, 2021
Published online: December 6, 2021